DE3674569D1 - 2-((3,5-dihalo-4-aminobenzyl))imidazole. - Google Patents

2-((3,5-dihalo-4-aminobenzyl))imidazole.

Info

Publication number
DE3674569D1
DE3674569D1 DE8686115057T DE3674569T DE3674569D1 DE 3674569 D1 DE3674569 D1 DE 3674569D1 DE 8686115057 T DE8686115057 T DE 8686115057T DE 3674569 T DE3674569 T DE 3674569T DE 3674569 D1 DE3674569 D1 DE 3674569D1
Authority
DE
Germany
Prior art keywords
aminobenzyl
dihalo
imidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686115057T
Other languages
English (en)
Inventor
Martin Winn
Bernardis John Francis De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE3674569D1 publication Critical patent/DE3674569D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DE8686115057T 1985-12-11 1986-10-30 2-((3,5-dihalo-4-aminobenzyl))imidazole. Expired - Fee Related DE3674569D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/807,921 US4665095A (en) 1985-12-11 1985-12-11 Use of 2-[(3,5-dihalo-4-aminobenzyl)]imidazolines to stimulate alpha-1 adrenergic receptors and to treat nasal congestion

Publications (1)

Publication Number Publication Date
DE3674569D1 true DE3674569D1 (de) 1990-10-31

Family

ID=25197433

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686115057T Expired - Fee Related DE3674569D1 (de) 1985-12-11 1986-10-30 2-((3,5-dihalo-4-aminobenzyl))imidazole.

Country Status (9)

Country Link
US (1) US4665095A (de)
EP (1) EP0230532B1 (de)
JP (1) JPH07116038B2 (de)
AU (1) AU591740B2 (de)
CA (1) CA1282334C (de)
DE (1) DE3674569D1 (de)
FI (1) FI865025A (de)
NO (1) NO864993L (de)
NZ (1) NZ218334A (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970240A (en) * 1989-10-18 1990-11-13 Schering Corporation Fruity flavored nasal decongestant composition
US5114979A (en) * 1989-10-18 1992-05-19 Schering Corporation Fruity flavored nasal decongestant composition
JP4096363B2 (ja) * 1997-03-14 2008-06-04 日本新薬株式会社 鼻又は眼の充血治療剤
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
WO1999057131A1 (en) * 1998-05-06 1999-11-11 Duke University Method of treating bladder and lower urinary tract syndromes
JP2009524617A (ja) * 2006-01-27 2009-07-02 エフ．ホフマン−ラ ロシュ アーゲー 置換２−イミダゾール又はイミダゾリン誘導体の使用
KR101172940B1 (ko) * 2006-10-19 2012-08-10 에프. 호프만-라 로슈 아게 트레이스 아민 관련 수용체에 대해 친화도를 갖는 아미노메틸-2-이미다졸
KR101176699B1 (ko) * 2006-10-19 2012-08-23 에프. 호프만-라 로슈 아게 아미노메틸-4-이미다졸
ATE533755T1 (de) * 2006-11-02 2011-12-15 Hoffmann La Roche Substituierte 2-imidazole als modulatoren der mit spurenaminen assoziierten rezeptoren
RU2456281C2 (ru) * 2006-11-16 2012-07-20 Ф. Хоффманн-Ля Рош Аг Замещенные 4-имидазолы, способ их получения и их применение
BRPI0720047A2 (pt) * 2006-12-13 2013-12-24 Hoffmann La Roche 2-imidazóis como ligantes para receptores associados a aminas de traço (taar)
US20080146523A1 (en) * 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
CA2675221C (en) * 2007-02-02 2016-02-23 F. Hoffmann-La Roche Ag Novel 2-aminooxazolines as taar1 ligands
KR101222412B1 (ko) * 2007-02-15 2013-01-15 에프. 호프만-라 로슈 아게 Ｔａａｒ1 리간드로서의 2-아미노옥사졸린
WO2009003868A2 (en) 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2 -imidazolines having a good affinity to the trace amine associated receptors (taars)
CA2691704A1 (en) * 2007-07-03 2009-01-08 F. Hoffmann-La Roche Ag 4-imidazolines and their use as antidepressants
BRPI0813837A2 (pt) * 2007-07-27 2015-01-06 Hoffmann La Roche 2-azetidinametanoaminas e 2-pirrolidinametanoaminas como ligantes de taar
WO2009016088A1 (en) * 2007-08-02 2009-02-05 F. Hoffmann-La Roche Ag The use of benzamide derivatives for the treatment of cns disorders
JP5341084B2 (ja) * 2007-08-03 2013-11-13 エフ．ホフマン−ラ ロシュ アーゲー Ｔａａｒ１リガンドとしてのピリジンカルボキシアミド及びベンズアミド誘導体
DK2207537T3 (en) * 2007-10-02 2017-10-02 Fremont Group Ltd Systemic pro-haemostatic effect of sympathomimetics with agonistic effects on alpha-adrenergic and / or beta-adrenergic receptors in the sympathetic nervous system, related to improved clot strength
US8242153B2 (en) * 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
RU2513086C2 (ru) * 2008-07-24 2014-04-20 Ф.Хоффманн-Ля Рош Аг Производные 4,5-дигидро-оксазол-2-ила
US20100311798A1 (en) * 2009-06-05 2010-12-09 Decoret Guillaume 2-aminooxazolines as taar1 ligands
US8354441B2 (en) * 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
AU2017234042B2 (en) 2016-03-17 2020-11-19 F. Hoffmann-La Roche Ag 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of TAAR
AU2018280236B2 (en) 2017-06-07 2024-06-06 Shifamed Holdings, Llc Intravascular fluid movement devices, systems, and methods of use
US11511103B2 (en) 2017-11-13 2022-11-29 Shifamed Holdings, Llc Intravascular fluid movement devices, systems, and methods of use
CN112004563A (zh) 2018-02-01 2020-11-27 施菲姆德控股有限责任公司 血管内血泵以及使用和制造方法
US11964145B2 (en) 2019-07-12 2024-04-23 Shifamed Holdings, Llc Intravascular blood pumps and methods of manufacture and use
WO2021016372A1 (en) 2019-07-22 2021-01-28 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
US11724089B2 (en) 2019-09-25 2023-08-15 Shifamed Holdings, Llc Intravascular blood pump systems and methods of use and control thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2731471A (en) * 1956-01-17 Nxg hi
US2868802A (en) * 1959-01-13 Nxchj
DE1617618B2 (de) * 1966-06-18 1976-05-20 Merck Patent Gmbh, 6100 Darmstadt Schleimhautabschwellende mittel zur lokalen applikation
DE1618005A1 (de) * 1966-09-22 1971-09-09 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-dihalogen-phenyl-aethylaminen
US3660423A (en) * 1970-02-13 1972-05-02 Dow Chemical Co 2-(substituted benzyl)methyl-2-imidazolines
US3922282A (en) * 1975-01-17 1975-11-25 American Home Prod 2-Aryl-2-imidazoline-1-propionic acids and their esters
AU1623483A (en) * 1978-02-01 1983-10-13 Wellcome Foundation Limited, The Formulations of imidazole derivatives
US4506074A (en) * 1982-11-08 1985-03-19 Merck & Co., Inc. 2-[2-Pyridinyloxy(thio or amino)methyl]-1H-imidazoles and derivatives
US4461914A (en) * 1983-02-01 1984-07-24 American Cyanamid Company Method for the preparation of 1-(4'-amino-3',5'-dichlorophenyl)-2-alkyl(or dialkyl)aminoethanols
FR2549049B1 (fr) * 1983-07-13 1986-06-20 Chauvin Blache Lab Nouvelles amidines, leur procede de preparation et leur application therapeutique

Also Published As

Publication number Publication date
JPS62145067A (ja) 1987-06-29
NO864993L (no) 1987-06-12
JPH07116038B2 (ja) 1995-12-13
FI865025A0 (fi) 1986-12-10
NO864993D0 (no) 1986-12-10
FI865025A (fi) 1987-06-12
AU591740B2 (en) 1989-12-14
AU6631986A (en) 1987-06-18
US4665095A (en) 1987-05-12
NZ218334A (en) 1989-03-29
EP0230532B1 (de) 1990-09-26
CA1282334C (en) 1991-04-02
EP0230532A1 (de) 1987-08-05

Similar Documents

Publication Publication Date Title
DE3674569D1 (de) 2-((3,5-dihalo-4-aminobenzyl))imidazole.
FI853193A0 (fi) Smaertstillande 1,2-benzisotiazol-3 -ylpiperazinderivat.
DE3669876D1 (de) 3,4-dihydrobenzopyranderivate.
FI863532A0 (fi) Raekneanordning foer fiskar, i synnerhet fiskyngel.
FI871692A0 (fi) Sorteringsmaskin, i synnerhet foer smaopaket.
MX21592A (es) 1,3-oxazolidin-2-ona.
NL971040I1 (nl) 1-Dimethylcarbamoyl-3-gesubstitueerde-5-gesubstitueerde-1H-1,2,4-triazolen.
ATE45741T1 (de) 1-oxa-3-oxo-4,8-diaza-spiro-(4,5>decanverbindungen.
IT8521944A0 (it) 1,4-diidropiridine-2-sostituite.
DE3585315D1 (de) 5,6,7,8-tetrafluoranthrachinonderivate.
FI86060B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,4-naftalendioner.
DE3586745D1 (de) 9,11-epoxy-21-hydroxypregnan-derivate.
NO863304D0 (no) 7-okso-4-tia-1-azabicyklo(3,2,0)hept-2-derivater.
FI861950A0 (fi) 1,3-dioxan-etrar.
DE3684900D1 (de) 2,2'-bi-1h-imidazole.
FI853421L (fi) 7-oxo-4-tia-1-azabicyklo/3,2,0/ hept-2-enderivat.
FI855182A (fi) Foerfarande foer framstaellning av 1,3 -disubstituerade tetrahydropyridiner.
FI865158A0 (fi) 1-h-pyrido/3,2//1,4/-tiaziner.
IT8620495A0 (it) 2,4-dicloro-5-nitro-tiazolo.
DE3674284D1 (de) Kationische 1,2,3-thiadiazolazoverbindungen.
ATE64389T1 (de) 1-dimethylcarbamoyl-3-substituierte-5substituierte-1h-1,2,4-triazole.
ATE45349T1 (de) Substituierte 2,3,4,9-tetrahydro-1h-carbazol-1essigs|urederivate.
NO892008D0 (no) Substituert 1,2,4-oksadiazol.
NO864343D0 (no) Substituerte 1,1,2-trifenylbut-1-ener.
ATE51400T1 (de) 3,4-dihydrobenzopyranderivate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee